358 related articles for article (PubMed ID: 1832771)
1. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.
Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Sorge JA; Putman DL; Short JM
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7958-62. PubMed ID: 1832771
[TBL] [Abstract][Full Text] [Related]
2. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector.
Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Putman DL; Sorge JA; Short JM
Environ Mol Mutagen; 1991; 18(4):316-21. PubMed ID: 1836179
[TBL] [Abstract][Full Text] [Related]
3. The use of transgenic mice for short-term, in vivo mutagenicity testing.
Kohler SW; Provost GS; Kretz PL; Fieck A; Sorge JA; Short JM
Genet Anal Tech Appl; 1990 Dec; 7(8):212-8. PubMed ID: 2151115
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
[TBL] [Abstract][Full Text] [Related]
5. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
[TBL] [Abstract][Full Text] [Related]
6. Development of a short-term, in vivo mutagenesis assay: the effects of methylation on the recovery of a lambda phage shuttle vector from transgenic mice.
Kohler SW; Provost GS; Kretz PL; Dycaico MJ; Sorge JA; Short JM
Nucleic Acids Res; 1990 May; 18(10):3007-13. PubMed ID: 1693420
[TBL] [Abstract][Full Text] [Related]
7. Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I).
Rogers BJ; Provost GS; Young RR; Putman DL; Short JM
Mutat Res; 1995 Mar; 327(1-2):57-66. PubMed ID: 7870099
[TBL] [Abstract][Full Text] [Related]
8. Development of a rat cell line containing stably integrated copies of a lambda/lacI shuttle vector.
Wyborski DL; Malkhosyan S; Moores J; Perucho M; Short JM
Mutat Res; 1995 Apr; 334(2):161-5. PubMed ID: 7885368
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous mutations in lacI-containing lambda lysogens derived from transgenic mice: the observed patterns differ in liver and spleen.
Knöll A; Jacobson DP; Kretz PL; Lundberg KS; Short JM; Sommer SS
Mutat Res; 1994 Nov; 311(1):57-67. PubMed ID: 7526175
[TBL] [Abstract][Full Text] [Related]
10. Ethylnitrosourea-induced mutation and molecular analysis of transgenic mice containing the gpt shuttle vector.
Yamada T; Yamamoto R; Kaneko H; Yoshitake A
Mutat Res; 1999 Apr; 441(1):59-72. PubMed ID: 10224323
[TBL] [Abstract][Full Text] [Related]
11. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
12. Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse.
You YH; Halangoda A; Buettner V; Hill K; Sommer S; Pfeifer G
Mutat Res; 1998 Dec; 420(1-3):55-65. PubMed ID: 9838042
[TBL] [Abstract][Full Text] [Related]
13. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE
Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
Zimmer DM; Harbach PR; Mattes WB; Aaron CS
Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
[TBL] [Abstract][Full Text] [Related]
16. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.
Shane BS; Lockhart AM; Winston GW; Tindall KR
Mutat Res; 1997 Jun; 377(1):1-11. PubMed ID: 9219573
[TBL] [Abstract][Full Text] [Related]
17. Development of a lambda-based complementation assay for the preliminary localization of lacI mutants from the Big Blue mouse: implications for a DNA-sequencing strategy.
Gu M; Ahmed A; Wei C; Gorelick N; Glickman BW
Mutat Res; 1994 Jun; 307(2):533-40. PubMed ID: 7514727
[TBL] [Abstract][Full Text] [Related]
18. Effect of target gene CpG content on spontaneous mutation in299 transgenic mice.
Skopek T; Marino D; Kort K; Miller J; Trumbauer M; Gopal S; Chen H
Mutat Res; 1998 May; 400(1-2):77-88. PubMed ID: 9685590
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived.
Hill KA; Buettner VL; Glickman BW; Sommer SS
Mutat Res; 1999 Jan; 436(1):11-9. PubMed ID: 9878678
[TBL] [Abstract][Full Text] [Related]
20. LacI mutation spectra following benzo[a]pyrene treatment of Big Blue mice.
Shane BS; de Boer J; Watson DE; Haseman JK; Glickman BW; Tindall KR
Carcinogenesis; 2000 Apr; 21(4):715-25. PubMed ID: 10753208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
